[vc_row][vc_column][vc_column_text]MTAA wrote to Minister Hunt before the election seeking a commitment to the medical devices industry to continue to honour the Agreement signed with the sector in 2017, and we were pleased that he responded with an assurance that the Agreement would be honoured.
The Agreement will save private health insurers $1.1 billion in payments for medical devices over the next four years and helped deliver the lowest private health premium increase in 18 years in December 2018.
A key part of the Agreement was the undertaking by Government to accelerate the process of listing non-implantable medical devices on the Prostheses List, to allow more Australians access to cutting edge technology.
The listing of catheter ablation technology on the Prostheses List was a significant step towards allowing privately insured patients greater access to life-saving non-implantable technology.
We look forward to continuing our productive relationship with Minister Hunt as we work together to ensure that Australians have access to the best possible medical technology in order to help them live longer and healthier lives.
We also welcome the re-appointment of the Hon Karen Andrews to the role of Industry, Science and Technology.[/vc_column_text][vc_zigzag][/vc_column][/vc_row][vc_row][vc_column width=”1/4″][vc_single_image image=”1585″ img_size=”full”][/vc_column][vc_column width=”3/4″][vc_column_text]
ABOUT THE AUTHOR
Ian Burgess is the CEO of the Medical Technology Association of Australia (MTAA).[/vc_column_text][/vc_column][/vc_row]